OTHER · Unmapped registry intervention
PHI-patients
Find medicine records ·
Find other trials using this name
Clinical trial
New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
NCT00908544
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
CHI-patients
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedNew Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV Infectionsunresolved
Interventions
PHI-patientsOTHER
CHI-patientsOTHER
Sponsors & collaborators
MUC Research GmbHlead sponsor
Merck Sharp & Dohme LLCcollaborator
AbbViecollaborator
Pfizercollaborator
German Center for Infection Researchcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00908544 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.